Long-term efficacy and safety of fourth-line multikinase inhibitor treatment with lenvatinib in a young papillary thyroid carcinoma patient

Por Morelli, S., Puxeddu, E.
Publicado no Drugs Context (2017)

Long-term safety and efficacy of Omnitrope(®) in adults with growth hormone deficiency: Italian interim analysis of the PATRO Adults study

Por Ferone, D., Profka, E., Gasco, V., Ambrosio, M. R., Colao, A., Di Somma, C., Puxeddu, E., Arnaldi, G., Pagano, C., Zecchi, E., Pietropoli, A., Beck-Peccoz, P.
Publicado no J Endocrinol Invest (2017)